Relmada Therapeutics Statistics
Total Valuation
RLMD has a market cap or net worth of $449.19 million. The enterprise value is $247.06 million.
| Market Cap | 449.19M |
| Enterprise Value | 247.06M |
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RLMD has 106.69 million shares outstanding. The number of shares has increased by 193.18% in one year.
| Current Share Class | 106.69M |
| Shares Outstanding | 106.69M |
| Shares Change (YoY) | +193.18% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 3.23% |
| Owned by Institutions (%) | 78.99% |
| Float | 82.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.32 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.37, with zero debt.
| Current Ratio | 26.37 |
| Quick Ratio | 26.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.66% and return on invested capital (ROIC) is -39.99%.
| Return on Equity (ROE) | -64.66% |
| Return on Assets (ROA) | -36.90% |
| Return on Invested Capital (ROIC) | -39.99% |
| Return on Capital Employed (ROCE) | -32.91% |
| Weighted Average Cost of Capital (WACC) | 7.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.86M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.67% in the last 52 weeks. The beta is 0.57, so RLMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +7.67% |
| 50-Day Moving Average | 3.77 |
| 200-Day Moving Average | 5.37 |
| Relative Strength Index (RSI) | 59.30 |
| Average Volume (20 Days) | 1,699,999 |
Short Selling Information
The latest short interest is 10.84 million, so 10.16% of the outstanding shares have been sold short.
| Short Interest | 10.84M |
| Short Previous Month | 12.18M |
| Short % of Shares Out | 10.16% |
| Short % of Float | 13.12% |
| Short Ratio (days to cover) | 6.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -65.00M |
| Pretax Income | -65.70M |
| Net Income | -65.70M |
| EBITDA | n/a |
| EBIT | -65.00M |
| Earnings Per Share (EPS) | -$0.71 |
Balance Sheet
The company has $202.12 million in cash and no debt, with a net cash position of $202.12 million or $1.89 per share.
| Cash & Cash Equivalents | 202.12M |
| Total Debt | n/a |
| Net Cash | 202.12M |
| Net Cash Per Share | $1.89 |
| Equity (Book Value) | 193.74M |
| Book Value Per Share | 1.82 |
| Working Capital | 197.27M |
Cash Flow
| Operating Cash Flow | -51.86M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -51.86M |
| FCF Per Share | -$0.49 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -193.18% |
| Shareholder Yield | -193.18% |
| Earnings Yield | -16.76% |
| FCF Yield | -11.54% |
Analyst Forecast
The average price target for RLMD is $10.75, which is 155.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.75 |
| Price Target Difference | 155.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 30, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |